Source: Annual Congress 2007 - Clinical physiology: blood gases, muscle function and ventilation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Klemmetsby, M. Voll-Aanerud, T. M. L. Eagan, P. S. Bakke (Bergen, Norway). Is sputum induction a safe procedure during COPD exacerbations?. Eur Respir J 2007; 30: Suppl. 51, 1138

Member's Comments

No comment yet.

Related content which might interest you: Sputum induction in severe exacerbations of asthma: safety of a modified method Source: Eur Respir J 2011; 38: 979-980 Year: 2011 Success rate and safety of sputum induction in severe exacerbations of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 93s Year: 2002 Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment? Source: Eur Respir J 2006; 28: Suppl. 50, 310s Year: 2006 Applications of induced sputum sampling in asthma and COPD Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 The success of obtaining the induced sputum of patients with COPD Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248-249 Year: 2013 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248 Year: 2013 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013